1910 Genetics

📍 Boston, United States🗓 Founded 2018👥 28 employees💰 Last funded Jan 2023
Biotechnology Research🌐 1910genetics.com
Website LinkedIn
1910 Genetics is the only biotechnology company advancing small and large molecule drug discovery with a multimodal AI platform powered by laboratory automation. We integrate AI with three proprietary data streams – computational data, wet lab proxy biological data, and wet lab ground truth biological data – to deliver novel drug candidates and software solutions to leading pharma and tech partners, and advance our internal pipeline for neurological, autoimmune diseases, and cancer. We are backed by leading investors including M12 - Microsofts Venture Fund, Playground Global, Sam Altman, Y Combinator, FoundersX Ventures, Scientia Ventures, and many others.
3
Total investors
2
Early stage
1
Mid stage
0
Late stage
2018
Founded

Investors

3 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
3
Investor activity2019–2023 · investors recorded per year
2019220231
Recent (last 2y)Earlier
Frequently asked questions
Who invested in 1910 Genetics?
1910 Genetics has 3 investors on record on gritt.io, including 2 early-stage backers, 1 mid-stage.
When did 1910 Genetics last raise funding?
The most recent investment in 1910 Genetics recorded on gritt.io was in January 2023.
When was 1910 Genetics founded?
1910 Genetics was founded in 2018.
What industry is 1910 Genetics in?
1910 Genetics operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is 1910 Genetics based?
1910 Genetics is headquartered in Boston, United States.